Finance
Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting
Start-up obtains S1PR modulator from Kyorin
A VC syndicate is backing Priothera with a €30 million ($35.5 million) series A round to develop a clinical S1PR modulator for